Amedica Group is the first-to-market and longest-running distributor of injectable polynucleotides, having proudly announced the launch of Ameela polynucleotide in June 2023 (previously known as Nucleadyn).
Ameela polynucleotides are extracted from salmon DNA and purified at high temperatures, which is a ground-breaking approach to regenerative medicine. This unique treatment ensures the recovery of a >95% pure active substance, free from proteins and hormones, guaranteeing product safety and the absence of immunological side effects. This innovative solution effectively restores skin firmness and elasticity, protecting the skin against free radicals and cellular damage.